Home ReNAgade Therapeutics

ReNAgade Therapeutics

acquired
Series A
RNA Drug Developer
Basic
Enterprise Profile

Basic Information

ReNAgade Therapeutics is a company that unleashes the infinite potential of RNA-based therapeutics to treat diseases. ReNAgade exists to unlock the potential of RNA medicines to address diseases in any part of the body. We combine our novel RNA delivery platform with a comprehensive RNA platform, enabling a full RNA system for coding, editing, and gene insertion to develop new drugs.
ReNAgade Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
101~500 people
January 01, 2021
info@renagadetx.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Application Scenarios
Innovative Drugs Nucleic Acid Drugs